Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation
April 2020 – Transplantation
angion publications
April 2020 – Transplantation
ANG-3070 is a Highly-Selective, Orally-Available TKI in Development for Pulmonary and Renal Fibrosis
May 2022 - American Thoracic Society Respiratory Innovation Summit
Phase 2 Study Design to Evaluate Safety and Efficacy of the Tyrosine Kinase Inhibitor ANG-3070 in Patients with Primary Proteinuric Kidney Disease
November 2021 - ASN Kidney Week
Effect of ANG-3070 in the Passive Heymann’s Nephritis Rat Model of Primary Proteinuric Kidney Disease
November 2021 - ASN Kidney Week
Effects of ANG-3070 in a Mouse Model of Alport Syndrome
November 2021 - ASN Kidney Week
Effect of ANG-3070 in the Unilateral Ureteral Obstruction Mouse Model of Renal Fibrosis
November 2021 - ASN Kidney Week
Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships with Renal Function and Graft Failure
June 2021 - American Transplant Congress
Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery–Associated Acute Kidney Injury
October 2020 - Kidney Reports International
The Effect of ANG-3777 on the Growth of c-Met Expressing Tumor Cells in Immunocompromised Mice
October 2020 - Kidney Week
Defining a Clinically-Meaningful Difference (MCMD) in Estimated Glomerular Filtration Rate (eGFR) for Kidney Transplantation
October 2020 - Kidney Week
Compartmental Differences Within the COL3A1 Network in Proteinuric Kidney Disease — Informing Drug Activity Using the Jaccard-Tanimoto Index
October 2020 - Kidney Week